The Wellness
Health News
Independent reporting on longevity, mental health, nutrition, performance, clinical developments and lifestyle medicine — drawn from authoritative sources including the Lancet, BMJ, WHO and NHS.
clinical · 21 Jun 2026MHRA Publishes Benefit-Risk Review of Avacopan
The Medicines and Healthcare products Regulatory Agency has published a formal assessment of the benefits and risks associated with avacopan, a treatment for certain rare autoimmune conditions.
- clinical · 21 Jun 2026
MHRA Publishes Benefit-Risk Review of Avacopan
The UK Medicines and Healthcare products Regulatory Agency has published a formal review examining the benefits and risks associated with avacopan, a treatment for certain rare autoimmune conditions.
- clinical · 20 Jun 2026
Oral GLP-1 Drug Elecoglipron Shows Promise in Phase 2b Trial
A phase 2b randomised trial published in The Lancet found that once-daily oral elecoglipron reduced glycaemia in adults with type 2 diabetes, with a tolerability profile consistent with the GLP-1 drug class.
- clinical · 20 Jun 2026
Oral GLP-1 Drug Elecoglipron Shows Promise in Phase 2b Trial
A phase 2b randomised trial published in The Lancet found that once-daily oral elecoglipron reduced glycaemia in adults with type 2 diabetes, with a tolerability profile consistent with its drug class.
lifestyle · 20 Jun 2026One Word or Two: The 'Health Care' Spelling Debate
A STAT News opinion piece argues that the spacing in 'health care' is more than a stylistic quirk, even as a reader poll found roughly 60% of respondents prefer the single-word form.
- lifestyle · 20 Jun 2026
Why Spelling 'Health Care' as Two Words Still Matters
A recent opinion piece in STAT News contends that the space between 'health' and 'care' is far from trivial — and a reader poll showing roughly 60% support for the single-word form sets up the debate.
clinical · 20 Jun 2026Eli Lilly Cuts 340B Drug Discounts at Dozens of Hospitals
Eli Lilly has moved to end federally mandated drug price breaks at a small number of hospitals enrolled in the 340B discount program, pointing to those facilities' failure to provide claims data as justification.
- clinical · 20 Jun 2026
Eli Lilly Cuts 340B Discounts at Hospitals Over Data Gap
Eli Lilly has moved to strip federally mandated drug discounts from a small group of hospitals enrolled in the 340B program, acting on a previously issued threat over missing claims data.
lifestyle · 20 Jun 2026Elizabeth Greenhall, Public Health Pioneer, Dies at 83
Elizabeth Greenhall, a consultant in public health who worked to broaden access to family planning and sexual health services in Oxfordshire, died at the age of 83.
- lifestyle · 20 Jun 2026
Elizabeth Greenhall, Public Health Pioneer, Dies at 83
Elizabeth Greenhall, a public health consultant whose career centred on expanding reproductive healthcare access for young women and marginalised communities, has died at the age of 83.
- clinical · 19 Jun 2026
frontMIND Trial Links Tafasitamab Combo to Longer PFS in DLBCL
Adding tafasitamab and lenalidomide to standard R-CHOP chemotherapy significantly extended progression-free survival in high-risk diffuse large B-cell lymphoma, though the combination also raised the rate of serious adverse events.
- clinical · 19 Jun 2026
Tafasitamab Combo Improves PFS in High-Risk DLBCL
Adding tafasitamab and lenalidomide to standard R-CHOP chemotherapy significantly extended progression-free survival in high-risk diffuse large B-cell lymphoma, according to a global phase 3 trial published in The Lancet — though the combination also raised safety concerns.
nutrition · 19 Jun 2026Oral GLP-1 Drugs Enter the Obesity Treatment Debate
A comment published in The Lancet explores the therapeutic potential of oral small-molecule GLP-1 receptor agonists, situating them within a shifting landscape of obesity and type 2 diabetes care.
- nutrition · 19 Jun 2026
Oral GLP-1 Drugs Emerge in Obesity and Diabetes Care
A comment published in The Lancet explores the therapeutic potential of oral small-molecule GLP-1 receptor agonists against a backdrop of shifting clinical priorities in obesity and type 2 diabetes management.
lifestyle · 19 Jun 2026NEJM Raises Questions About Lifestyle Change
A recent entry in the New England Journal of Medicine addresses a foundational question in health research: whether lifestyle change is genuinely possible. The piece signals continued interest in this unsettled area.
- lifestyle · 19 Jun 2026
NEJM Asks Whether Health Behaviour Change Is Possible
A commentary published in the New England Journal of Medicine reopens a foundational question in preventive medicine: whether meaningful, lasting change in health behaviour is genuinely attainable.
- lifestyle · 19 Jun 2026
UKHSA Releases AMR Awareness Toolkit for England
The UK Health Security Agency has published a guidance toolkit aimed at healthcare providers in England, offering resources tied to two international antimicrobial resistance awareness initiatives.
- lifestyle · 19 Jun 2026
Brazil Pauses Butantan Dengue Vaccine Programme
Brazilian health authorities have halted the Butantan Institute's dengue vaccine immunisation programme, describing the pause as precautionary while a safety investigation proceeds.
- clinical · 18 Jun 2026
UKHSA Issues PGD Template for Flu Vaccines IIV and LAIV
The UK Health Security Agency has released a patient group direction template to support the administration of two types of influenza vaccine as part of the national seasonal flu vaccination programme.
- clinical · 18 Jun 2026
UKHSA Issues Updated Flu Vaccine PGD Template
The UK Health Security Agency has released a patient group direction template to support administration of two influenza vaccine types under the national seasonal flu vaccination programme.
lifestyle · 18 Jun 2026Congenital Syphilis Rates Draw Physician Alarm
A physician and former public health official has described congenital syphilis as one of the most pressing concerns of his career, according to an opinion piece published by STAT News.
clinical · 17 Jun 2026FDA Shows Openness to Moderna Flu Vaccine Before Advisory Review
Regulators appear open to Moderna's influenza vaccine before a formal advisory committee review, STAT News reports, alongside other notable biotech developments.
nutrition · 17 Jun 2026GLP-1 Microdosing for Weight Loss Draws Safety Concerns
A weight-loss doctor has raised concerns about the growing use of GLP-1 medications in small, so-called microdoses for cosmetic weight loss, warning that long-term safety data for this application remains absent.
mental-health · 17 Jun 2026Two Alzheimer's Brain Scans Yield Different Results
A multicentre study published in The Lancet found that the choice of radioactive tracer used in tau PET brain imaging meaningfully affects how often Alzheimer's-related pathology is detected.
- lifestyle · 16 Jun 2026
Cuba Hospital Crisis Deepens as Oil Shortage Drives Blackouts
Cuban hospitals are struggling to maintain lifesaving equipment as nationwide blackouts stretching up to 20 hours follow the country's exhaustion of oil supplies, according to reporting by the BMJ.
clinical · 16 Jun 2026Genomic Test May Spare Breast Cancer Patients Chemotherapy
A genomic test trialled in breast cancer patients could allow millions to forgo chemotherapy entirely, with researchers reporting near-identical survival outcomes for those treated with hormone therapy alone.
performance · 15 Jun 2026NEJM Frames Self-Insured Employers as Untapped Cost Force
A commentary published in the New England Journal of Medicine characterises self-insured employers as an underutilised force in efforts to address health care affordability.
clinical · 15 Jun 2026Pfizer Has Not Fulfilled Emergency Penicillin Donation Request
Pfizer has not fulfilled a request to donate emergency penicillin to state health agencies, according to STAT News — a measure that was intended to serve as a safeguard against congenital syphilis.
lifestyle · 15 Jun 2026Australia Records First Diphtheria Death in Decades-Long Outbreak
Australia has confirmed a fatality linked to diphtheria as the country faces what is being described as its worst outbreak in decades, with cases reported across several states and territories.
lifestyle · 15 Jun 2026New Grantmaking Rule Draws Sharp Rebuke From Medical Research Leaders
The president of the Association of American Medical Colleges has described a new federal grantmaking rule as the gravest threat to scientific integrity he has encountered across a four-decade research career.
mental-health · 15 Jun 2026Career Change at 60: What Nursing Apprenticeships Reveal
When the Covid pandemic stripped the meaning from his decades-long engineering career, Nick Dowling enrolled in a nursing apprenticeship at 60 — trading a familiar salary for 12-hour shifts and a profound rethinking of professional identity.
lifestyle · 14 Jun 2026Real-Time Disease Data Fails to Calm Public Fear
Concurrent hantavirus and Ebola outbreaks have brought dashboards and disease trackers back into public view, but the return of these tools has not produced clearer or more confident public understanding of risk.
lifestyle · 14 Jun 2026Hospital Executives Debate Healthcare Cost Reduction
Hospital finance leaders gathered recently to discuss the persistent problem of high healthcare costs, though agreement on workable solutions proved difficult to reach.
lifestyle · 14 Jun 2026Funding Cuts and Rights Erosion Heighten HIV Epidemic Risk
UNAids has issued a stark warning that collapsing financial support for HIV programmes, combined with the erosion of human rights protections, is raising the prospect of a renewed epidemic.
lifestyle · 14 Jun 2026NIH Grant Cap Proposal Draws Cautious Support
The National Institutes of Health has proposed capping the number of grants available to individual scientists, a policy shift that has drawn cautious approval from parts of the research community.
- lifestyle · 13 Jun 2026
Genetic Roots of Coronary Artery Disease Examined
A newly published piece in the New England Journal of Medicine examines the genetic foundations of coronary artery disease, one of the leading causes of death worldwide.
- clinical · 13 Jun 2026
Atrasentan Shows Kidney Benefits in IgA Nephropathy Trial
A large phase 3 trial published in The Lancet found that atrasentan reduced proteinuria and helped preserve kidney function in patients with IgA nephropathy over a 2.5-year follow-up period.
nutrition · 13 Jun 2026Farm Bill Caps on Imports Could Remove Bananas From School Lunches
Proposed caps on imported foods under a new US Farm Bill could see bananas disappear from school cafeterias, with nutrition advocates warning the policy may undermine children's access to healthy, appealing meals.
- lifestyle · 13 Jun 2026
Cruise Ship Medicine: Beyond the Headlines
A hantavirus outbreak aboard the MV Hondius brought cruise ship medicine into the spotlight, but a new Lancet report suggests the reality of clinical work at sea is far more routine.
- clinical · 12 Jun 2026
SPIRIT-ROUTINE Extends Trial Protocol Guidance
A new extension to the widely adopted SPIRIT framework aims to strengthen how researchers design and report randomised controlled trial protocols that draw on cohort and routinely collected data.
- clinical · 12 Jun 2026
England Plans One-Off MenB Vaccine Drive for Young People
The UK Health Security Agency has announced a one-off programme to offer a two-dose meningococcal B vaccine to thousands of young people in England, with rollout planned before autumn.
clinical · 12 Jun 2026Nonprofit Buys Discontinued Cancer Drug to Preserve Access
Blood Cancer United, a nonprofit organization, has acquired the remaining stock of a discontinued investigational cancer drug in an effort to preserve access for patients who depend on the experimental treatment.
clinical · 11 Jun 2026Synthetic Lethality in Cancer Research May Spur Biotech M&A
Researchers are examining synthetic lethality as a potential cancer treatment strategy, though the science requires substantial further validation before its full implications become clear.
- clinical · 11 Jun 2026
PRISMA-C Extends Reporting Standards to Paediatric Reviews
A newly developed reporting checklist aims to address gaps in how systematic reviews of children's health interventions are conducted and communicated, according to a BMJ commentary.
lifestyle · 11 Jun 2026Medicare Advantage Plans Found Blocking Rehab Care
A federal investigation has found that private Medicare Advantage plans are systematically blocking access to rehabilitation care for older adults, with profit-driven motives implicated in the denials.
lifestyle · 11 Jun 2026US Measles Cases Top 2,000 in 2026 Outbreak
The United States has recorded more than 2,000 confirmed measles cases in 2026 alone, putting the country on course for its worst measles year in decades as declining vaccination rates and public health funding cuts compound the crisis.
lifestyle · 11 Jun 2026ACOG Issues Pregnancy Vaccine Schedule Diverging from CDC
The American College of Obstetricians and Gynecologists has published a recommended vaccine schedule for use during pregnancy that diverges from current CDC guidance, marking a notable split between the specialty organization and federal public health recommendations.
- lifestyle · 10 Jun 2026
UKHSA Releases Toolkit on Immunisation Inequities
The UK Health Security Agency has released a practical toolkit aimed at helping local and regional public health stakeholders understand and act on gaps in immunisation coverage.
lifestyle · 10 Jun 2026Five Diabetes Experts Expelled from ADA Meeting Over NIH Protest
Five diabetes experts were escorted out of an American Diabetes Association annual meeting after handing out an editorial critical of NIH funding cuts, triggering condemnations across the diabetes community.
- lifestyle · 10 Jun 2026
UKHSA Sets Out Flu Vaccination Plans for 2026–27
The UK Health Security Agency has released official correspondence detailing the structure of the national flu vaccination programme for the 2026 to 2027 season.
- clinical · 9 Jun 2026
MHRA Launches AI Sandbox for Medicines Development
The UK medicines regulator has introduced an AI sandbox initiative intended to speed up drug development, strengthen safety oversight, and reduce dependence on animal testing.
clinical · 9 Jun 2026GSK Agrees to Acquire Nuvalent in $10.6B Oncology Deal
Pharmaceutical giant GSK has reached an agreement to purchase Nuvalent, a company focused on targeted cancer therapies, for $10.6 billion, according to STAT News.
- clinical · 9 Jun 2026
MHRA Issues Field Safety Notices for Early June 2026
Regulators have released a fresh set of Field Safety Notices covering the opening days of June 2026, continuing routine oversight of medical devices in circulation.
nutrition · 9 Jun 2026Muscle Loss and Obesity Injections: What Research Shows
A notable proportion of weight lost through obesity injections such as Ozempic may come from muscle rather than fat, experts have warned, prompting efforts to develop a counteracting drug.
clinical · 8 Jun 2026J&J Pays $1 Billion to Acquire KRAS-Focused Startup Firefly Bio
Johnson & Johnson has announced a $1 billion deal to purchase Firefly Bio, a move that positions the pharmaceutical giant within one of oncology's most actively pursued research areas: KRAS inhibition.
clinical · 8 Jun 2026Richard Scolyer, Melanoma Pioneer, Dies at 59
Professor Richard Scolyer, a pathologist and melanoma researcher whose work helped shape modern immunotherapy, died at the age of 59 after being diagnosed with inoperable brain cancer in 2023.
- clinical · 8 Jun 2026
Survodutide Tested in Phase 3 MASLD Obesity Trial
A late-stage clinical trial published in Nature Medicine has evaluated survodutide in adults living with both obesity and metabolic dysfunction-associated steatotic liver disease.
clinical · 8 Jun 2026Revolution Medicines' Pancreatic Cancer Drug Draws Early Expansion Talk
An investigational drug from Revolution Medicines targeting pancreatic cancer has yet to receive regulatory approval, though early discussions about expanding its use are already underway.
- lifestyle · 7 Jun 2026
Climate Change Linked to Shifting Infectious Disease Patterns
A newly published paper in Nature Medicine points to an emerging body of evidence connecting climate change with shifts in how and where infectious diseases spread.
- clinical · 7 Jun 2026
PCSK9 Gene Therapy Enters Early Clinical Trials
An experimental gene therapy designed to suppress PCSK9, a protein central to cholesterol regulation, has entered early-stage clinical trials, with researchers describing the development as a potentially significant moment in cardiovascular medicine.